Retatrutid

Neue Ära in der Stoffwechselmedizin: Von PCOS bis Retatrutid – AD HOC NEWS

by

The landscape of metabolic health is undergoing a significant transformation, marked by both a shift in clinical nomenclature and the emergence of promising pharmacological interventions. As a physician, I have closely observed how our understanding of complex endocrine conditions—most notably the condition historically known as Polycystic Ovary Syndrome (PCOS)—is evolving to better reflect the multisystemic … Read more

Eli Lilly’s Retatrutid Achieves Weight Loss Comparable to Gastric Bypass; EMA Recommends Wegovy Pill Approval

by

The landscape of obesity treatment is undergoing a fundamental transformation as pharmaceutical innovation begins to mirror the clinical outcomes historically reserved for bariatric surgery. As a physician and health journalist, I have followed the evolution of metabolic medicine for over a decade, and the current shift toward highly potent injectable therapies represents a significant milestone … Read more